Veradigm Inc (MDRX)
OTCMKTS: MDRX · Delayed Price · USD
9.55
+0.05 (0.53%)
Jul 8, 2024, 2:54 PM EDT - Market open
Veradigm Employees
Veradigm had 8,000 employees as of December 31, 2021. The number of employees decreased by 400 or -4.76% compared to the previous year.
Employees
8,000
Change (1Y)
-400
Growth (1Y)
-4.76%
Revenue / Employee
n/a
Profits / Employee
n/a
Market Cap
1.03B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2021 | 8,000 | -400 | -4.76% |
Dec 31, 2020 | 8,400 | -1,200 | -12.50% |
Dec 31, 2019 | 9,600 | 100 | 1.05% |
Dec 31, 2018 | 9,500 | 600 | 6.74% |
Dec 31, 2017 | 8,900 | 1,400 | 18.67% |
Dec 31, 2016 | 7,500 | 600 | 8.70% |
Dec 31, 2015 | 6,900 | -300 | -4.17% |
Dec 31, 2014 | 7,200 | 0 | - |
Dec 31, 2013 | 7,200 | 100 | 1.41% |
Dec 31, 2012 | 7,100 | 800 | 12.70% |
Dec 31, 2011 | 6,300 | 3,872 | 159.47% |
May 31, 2010 | 2,428 | 59 | 2.49% |
May 31, 2009 | 2,369 | 1,214 | 105.11% |
Jan 1, 2008 | 1,155 | 241 | 26.37% |
Jan 1, 2007 | 914 | 528 | 136.79% |
Jan 1, 2006 | 386 | 38 | 10.92% |
Jan 31, 2005 | 348 | 18 | 5.45% |
Jan 31, 2004 | 330 | 26 | 8.55% |
Feb 28, 2003 | 304 | -62 | -16.94% |
Feb 28, 2002 | 366 | -125 | -25.46% |
Feb 28, 2001 | 491 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
MDRX News
- 26 days ago - Black Book ranks Veradigm Payer Analytics the #1 Overall Payer Analytics Solutions Vendor in 2024 - Business Wire
- 27 days ago - The Portnoy Law Firm Announces Investigation of Veradigm Inc. (OTCMKTS: MDRX) - GlobeNewsWire
- 4 weeks ago - Robbins LLP Reminds MDRX Stockholders it is Investigating the Officers and Directors of Veradigm Inc. to Determine if They Breached Fiduciary Duties Owed to Shareholders - Business Wire
- 4 weeks ago - Robbins LLP Informs Investors it is Investigating the Officers and Directors of Veradigm Inc. (MDRX) for Breaches of Fiduciary Duty - GlobeNewsWire
- 5 weeks ago - Veradigm Payerpath Rated Highest in Client Satisfaction - Business Wire
- 5 weeks ago - Veradigm to Explore Strategic Alternatives and Reaffirms 2024 Guidance - Business Wire
- 5 weeks ago - Veradigm Announces Leadership Updates - Business Wire
- 7 weeks ago - Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Veradigm Inc. (MDRX) on Behalf of Investors - Business Wire